The GLP-1 weight loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound can cause blindness.
America’s drug regulator, the Food and Drug Administration (FDA), has warned that the drugs can cause a rare eye condition known as nonarteritic anterior ischemic optic neuropathy (NAION) that blocks oxygen to the optic nerves, leading to vision loss and even blindness.
It has ordered the manufacturers to add the warning to the drug sheets after it conducted a review that concluded that there was an “increased risk of rare NAION events” in people taking the drugs.
Studies the FDA looked at included one published two years ago that concluded that semaglutide—the drugs’ most active ingredient—raised the risk of NAION four-fold. Last year, the European Medicines Agency said up to 1 in 10,000 people taking semaglutide may be affected by NAION.
Pancreatitis and gallbladder disease are already associated with the drugs, while semaglutide can cause nausea, vomiting and stomach pain.
What do you think? Start a conversation over on the... WDDTY Community
Great news! Discounts are available based on your cart total. Check the details below: